Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Mori T, Ito S: Sitagliptin, a dipeptidyl peptidase-4 inhibitor, decreases systolic blood pressure in Japanese hypertensive patients with type 2 diabetes
If side effects persist or interfere with daily function, your provider may adjust the dose, timing, or recommend supportive strategies like dietary modifications or temporary medication pauses
4c, 4e)
Beyond drugs, a growing number of companies are targeting the behavioral side of weight loss, combining these approaches with GLP-1 treatments to improve outcomes
Up until 2019, GLP-1 RAs were only injectable medications when Rybelsus, the first oral GLP-1 came to market
How to get prior authorization for Mounjaro